1.Anti-Myeloperoxidase (MPO) associated Vasculitis in a young Filipino Male with Bronchiectasis: A case report
Antonio Lorenzo R. Quiambao ; Ester G. Penserga
Philippine Journal of Internal Medicine 2022;60(3):211-214
Background:
ANCA-associated vasculitis and its subtypes have been associated with pulmonary manifestations, with bronchiectasis being a unique clinical presentation.
Case Summary
We report the case of a 26-year-old Filipino male who presented with progressive dyspnea, neuropathic
pain, and purpuric rash. Diagnostic evaluation revealed upper lobe bronchiectasis and lower lobe pneumonia, as well as hematuria and proteinuria. ANCA-associated vasculitis (AAV) and tuberculosis were considered. There was improvement of dyspnea, cough and rashes with antibiotics, glucocorticoids (GC), and anti-TB coverage. However, neuropathic pain progressed to the upper and lower extremities with development of weakness. Anti-myeloperoxidase (MPO) Anti-Neutrophil Cytoplasmic Antibody (ANCA) was positive, Electromyography-Nerve Conduction Velocity (EMG-NCV) revealed diffuse sensorimotor axonal polyradiculopathy of both upper and lower extremities. Cyclophosphamide was then given. The patient gradually regained his motor strength while sensory deficits persisted. He was referred to rehabilitation medicine for physical therapy and eventually discharged. This case highlights vasculitis as an associated extrapulmonary manifestation of bronchiectasis, and the possible role of bronchiectasis in the immune-mediated pathogenesis of ANCA- associated vasculitides.
Bronchiectasis
;
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
4.Severe Symptomatic Hyponatremia Caused by Low Dose Oral Cyclophosphamide: A Case Report.
Seungkyo PARK ; Woojeung KIM ; Hoon Young CHOI ; Ji Hyun YOON ; Sung Kyu HA ; Hyeong Cheon PARK
Korean Journal of Nephrology 2011;30(6):647-650
Cyclophosphamide (CY), an alkylating agent, is frequently used in the treatment of various autoimmune disorders and malignancies. Acute hyponatremia is a well-known side effect of moderate to high dose intravenous CY treatment, but is rare in patients treated with low dose intravenous CY. We report the case of a severe symptomatic hyponatremia in a 68-year-old woman with renal impairment who was treated with oral CY (100 mg/day) for anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis (GN). This case demonstrates that even oral CY could be associated with life threatening acute hyponatremia and should be used with caution.
Aged
;
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
;
Antibodies, Antineutrophil Cytoplasmic
;
Cyclophosphamide
;
Female
;
Glomerulonephritis
;
Humans
;
Hyponatremia
5.ANCA-Associated Vasculitis Presenting with Hypertrophic Pachymeningitis
So Yeon KWON ; Ho chang LEE ; Sung Hyun LEE
Journal of the Korean Neurological Association 2018;36(3):243-245
No abstract available.
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
;
Antibodies, Antineutrophil Cytoplasmic
;
Glomerulonephritis
;
Meningitis
7.ANCA-Associated Vasculitic Neuropathy with Concurrent Pulmonary Tuberculosis.
Jung Im SEOK ; Sung Hoon PARK ; Kyung Chan KIM
Journal of the Korean Neurological Association 2012;30(1):42-44
Antineutrophil cytoplasmic antibodies (ANCA) are closely linked to primary systemic vasculitis, and ANCA detection has became an important diagnostic hallmark of ANCA-associated vasculitis (AAV). However, it has been reported that tuberculosis is associated with positivity for ANCA and it is difficult to differentiate clinically between tuberculosis and AAV. We report a patient with the concomitant appearance of AAV and pulmonary tuberculosis. Positivity for ANCA should be carefully interpreted as indicative of AAV, especially in countries with a high prevalence of tuberculosis.
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
;
Antibodies, Antineutrophil Cytoplasmic
;
Humans
;
Peripheral Nerves
;
Prevalence
;
Systemic Vasculitis
;
Tuberculosis
;
Tuberculosis, Pulmonary
8.Anti-neutrophil cytoplasmic antibody-associated vasculitis with gastrointestinal bleeding as the main symptom: a case report and literature review.
Fei TIAN ; Zhaohui ZHANG ; Lingyun ZHANG ; Min LIU ; Jinglan LIU ; Xingguang QU ; Shengmin GUI ; Xiaoyun XU
Chinese Critical Care Medicine 2023;35(4):431-434
Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) has a wide range of symptoms, and it is difficult for clinicians to make a quick and correct diagnosis. On November 11, 2021, a 36-year-old male patient with AAV was admitted to the emergency and critical care department of Yichang Central People's Hospital. He was admitted to the emergency intensive care unit (EICU) with gastrointestinal symptoms (abdominal pain, black stool) as the main physical signs, and was initially diagnosed as AAV with gastrointestinal hemorrhage (GIH). No bleeding point was found after repeated gastroscopy and colonoscopy. Abdominal emission CT (ECT) showed diffuse hemorrhage in the ileum, ascending colon and transverse colon. Multi-disciplinary consultation in the whole hospital considered the diffuse hemorrhage caused by small vascular lesions in the digestive tract caused by AAV. Pulse therapy with methylprednisolone 1 000 mg/d and immunosuppressive therapy with cyclophosphamide (CTX) 0.2 g/d were administered. The patient's symptoms quickly relieved and transferred out of the EICU. After 17 days of treatment, the patient finally died of massive gastrointestinal bleeding. A systematic review of relevant literatures combined with the case diagnosis and treatment process found that only a minority of AAV patients present with gastrointestinal symptoms as their first symptoms, and patients with GIH were very rare. Such patients had a poor prognosis. This patient delayed the use of induced remission and immunosuppressive agents due to the treatment of gastrointestinal bleeding, which may be the main cause of life-threatening GIH secondary to AAV. Gastrointestinal bleeding is a rare and fatal complication of vasculitis. Timely and effective induction and remission treatment is the key to survival. Whether patients should receive maintenance therapy, the duration of maintenance therapy, and the search for markers of disease diagnosis and treatment response are directions and challenges for further research.
Male
;
Humans
;
Adult
;
Gastrointestinal Hemorrhage
;
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
;
Critical Care
;
Cyclophosphamide
;
Death
10.Renal Amyloidosis Secondary to ANCA-Associated Vasculitis: A Case Report.
He XIN ; Ning JIAN-PING ; Xu HUI ; Xiao GONG ; Yang HUI-XIANG ; Wang WEI-YUAN ; Wu XIAO-YING ; Yin HONG-LING ; Li XIAO-ZHAO
Chinese Medical Sciences Journal 2022;37(4):359-362
Renal amyloidosis secondary to anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is extremely rare. Here, we reported a 77-year-old woman with ANCA-associated vasculitis. Renal biopsy with Masson trichrome staining showed pauci-immune crescentic glomerulonephritis, and electron microscopy showed amyloid deposition in the mesangial area. Immunofluorescence revealed kappa light chain and lambda light chain negative. Bone marrow biopsy revealed no clonal plasma cell. Finally, she was diagnosed as ANCA-associated vasculitis with secondary renal amyloid A amyloidosis.
Female
;
Humans
;
Aged
;
Glomerulonephritis/diagnosis*
;
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/pathology*
;
Antibodies, Antineutrophil Cytoplasmic
;
Kidney/pathology*
;
Amyloidosis/complications*